Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

66455 1511539639HCLSTunisiaNovember2017.pdf
Energy Boardroom

Regeneron chief outranks every other biopharma CEO with $36M in 2013 pay

30.04.2014 / Fierce Pharma

Last year, little Regeneron gave its top executives a big payday. The company's vision-loss drug Eylea was breaking sales records left and right. Its colon cancer drug, developed with Sanofi, had hit the market. And the company's board figured that keeping its key people was worth millions–a total of $140 million, in fact, mostly in stock and option awards.

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: